Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions

Anlauf, M.; Perren, A.; Henopp, T.; Rudolph, T.; Garbrecht, N.; Schmitt, A.; Raffel, A.; Gimm, O.; Weihe, E.; Knoefel, W. T.; Dralle, H.; Heitz, Ph. U.; Komminoth, P.; Klöppel, G.
May 2007
Gut;May2007, Vol. 56 Issue 5, p637
Academic Journal
Background: Patients with a multiple endocrine neoplasia type 1 (MEN1)-associated Zollinger-Ellison syndrome (ZES) show multifocal duodenal gastrinomas and precursor lesions. Aims: To test these lesions for loss of heterozygosity (LOH) of the MEN1 gene locus on chromosome 11q13, and to investigate whether the MEN1-related endocrine cell changes also involved somatostatin cells. Material and methods: Tissue specimens from six patients with MEN1 and ZES were analysed by immunohistochemistry and immunofluorescence. LOH analysis was performed by fluorescence in situ hybridisation (FISH), using probes containing the MEN1 gene locus and the centromere 11 (C11) region. For simultaneous analysis of hormones and allelic deletions, a combined FISH/immunofluorescence protocol was established. Results: 28 of a total of 33 duodenal neuroendocrine tumours (NETs) were gastrin-producing tumours; 13/28 (46.4%) revealed LOH on 11q13 and/or C11. Five of the NETs were somatostatin-expressing tumours, two revealing LOH. Allelic loss was detected in tumours as small as 300 μm (gastrin) and 400 μm (somatostatin) in diameter. The gastrin-producing tumours showed different deletion/retention patterns. Hyperplastic somatostatin cell lesions, similar to those of the gastrin cells, were present in all patients. The hyperplastic lesions of both cell lines consistently retained both 11q13 alleles. Conclusions: Allelic deletion of the MEN1 gene may reflect a pivotal event in the development of multifocal gastrin and somatostatin cell neoplasms in the duodenum of patients with MEN1. The observation of distinct deletion patterns in small synchronous tumours supports the concept that each gastrin-producing tumour in an individual MEN1 patient arises from an independent cell clone.


Related Articles

  • Zollinger-Ellison Syndrome. Kusakcioglu, Oznur; Heffernon, Elmer W. // American Journal of Gastroenterology;Aug1967, Vol. 48 Issue 2, p110 

    Presents clinical information on the Zollinger-Ellison syndrome. Symptoms associated with the syndrome; Incidence of the coexistence of adrenal medullary tumors and peptic ulcer; Pathological description of a case of a patient with Zollinger-Ellison syndrome.

  • Zollinger-Ellison Syndrome.  // Encyclopedic Reference of Molecular Pharmacology;2004, p1017 

    A definition of the term "Zollinger-Ellison Syndrome" is presented. It refers to a disease characterized by the development of a tumor (gastrinoma) or tumors that secrete excessive levels of gastrin, a hormone that stimulates production of acid by the stomach. In most cases, the tumor or tumors...

  • Giant gastrinoma in a patient with multiple endocrine adenopathy (type 1). Vella, M. A.; Gorsuch, A. N.; Cowie, A. G. A.; Watson, L. C. A. // Journal of the Royal Society of Medicine;Jun1988, Vol. 81 Issue 6, p359 

    The article presents a case of a 36 year-old white female who had a multiple endocrine adenopathy Type-1 and undergone a gastrectomy because of Zollinger-Ellison syndrome. The occurrence of endocrine adenopathy in patient is commonly associated with pancreatic islet cell tumor. In using gastrin...

  • SHOULD THE 1996 CITATION FOR ZOLLINGER- ELLISON SYNDROME READ: "ACID-REDUCING SURGERY IN, AGGRESSIVE RESECTION OUT"? Jensen, Robert T. // American Journal of Gastroenterology;Jun1996, Vol. 91 Issue 6, p1067 

    Reviews several studies on Zollinger-Ellison syndrome (ZES). Treatment of the gastric hyper section in patients with ZES; Controversy over the use of surgery directed against gastrinoma; Evolution of the treatment of gastric acid hyper section and the gastrinoma in patients with ZES.

  • Unusual imaging appearances of pancreatic serous cystadenoma: correlation with surgery and pathologic analysis. Takeshita, K.; Kutomi, K.; Takada, K.; Kohtake, H.; Furui, S.; Takada, T.; Fukushima, J. // Abdominal Imaging;Sep/Oct2005, Vol. 30 Issue 5, p610 

    Background: We describe imaging and pathologic features of serous cystadenoma of the pancreas on multislice helical computed tomography CT (MS-CT) and surgical resection. Methods: Radiologic and pathologic features were analyzed in five patients. All patients underwent MS-CT and digital...

  • 14th International workshop on multiple endocrine neoplasia and other rare endocrine tumors.  // Wiener Klinische Wochenschrift;Aug2014 Supplement, Vol. 126, p139 

    The article offers information on the 14th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors to be held on September 25-27, 2014 in Vienna, Austria.

  • Multiple Endocrine Neoplasia Type 4 (MEN4) Syndrome. Şimşir, Ilgın Yıldırım; Ertan, Yeşim; Sözbilen, Murat; Makay, Özer; Erdoğan, Mehmet; Çetinkalp, Şevki; Saygılı, L. Füsun; Yılmaz, Candeğer; Berdeli, Afig; Özgen, A. Gökhan // Journal of Clinical Research in Pediatric Endocrinology;2015 Supplement, Vol. 7, p44 

    An abstract of the article "Multiple Endocrine Neoplasia Type 4 (MEN4) Syndrome," by Ilgın Yıldırım Şimşir and colleagues is presented.

  • Zollinger-Ellison syndrome. Moore, Andrew Robert; Varro, Andrea; Pritchard, Mark // Gastrointestinal Nursing;Jun2012, Vol. 10 Issue 5, p44 

    Zollinger-Ellison syndrome is characterised by severe, recurrent peptic ulceration, gastro-oesophageal reflux and diarrhoea. It results from the overproduction of gastric acid, due to production of the hormone gastrin by a secretory tumour, or 'gastrinoma'. These rare neuroendocrine tumours are...

  • Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome. Imamura, Masayuki; Komoto, Izumi; Ota, Shuichi // World Journal of Surgery;Jan2006, Vol. 30 Issue 1, p1 

    We overviewed the recent development of curative surgery for gastrinoma that has been rapidly improved since the development of new localization techniques, especially the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy (SRS). A number of new...


Read the Article


Sign out of this library

Other Topics